Clinical Report: Women’s Perceived Usefulness of Generative AI–Based Digital Therapeutics

Overview

The article frames women’s perceived usefulness and adoption intentions for generative AI–based digital therapeutics (DTx) within gendered constraints on healthcare access, including caregiving and time demands. It describes a cross-sectional partial least squares structural equation modeling (PLS-SEM) analysis, but the supplied material does not include its sample, numerical results, or specific model findings.

Background

The COVID-19 pandemic accelerated digitally mediated healthcare, while also increasing exposure to digital treatment approaches. DTx are software-delivered, evidence-based therapeutic devices intended to prevent, manage, or treat disease, and differ from clinician-directed telemedicine by enabling patient participation in automated therapeutic processes. Generative AI may provide an intuitive text-based interface for self-management, although perceptions of AI vary across users and contexts. The article highlights that caregiving, pregnancy, childbirth, childcare, and household responsibilities can restrict women’s time to access healthcare, making gendered circumstances relevant to technology-acceptance research.

Data Highlights

The supplied article context identifies a cross-sectional PLS-SEM analysis but provides no sample size, measures, coefficients, statistical significance, or other numerical study results. No quantitative findings can therefore be reported.

Key Findings

• The study examines women’s perceived usefulness of generative AI–based DTx and their intentions to adopt them using a cross-sectional PLS-SEM approach.
• The article defines DTx as software-delivered, evidence-based therapeutic devices intended to prevent, manage, or treat disease.
• Unlike conventional telemedicine, DTx are described as enabling patients to participate directly in automated therapeutic processes based on clinical evidence.
• The article identifies gendered time and access constraints associated with caregiving, pregnancy and childbirth, childcare, and household labor as relevant context for technology acceptance.
• The authors frame acceptance structure as a higher-order cognitive framework that incorporates judgments differentiated by therapeutic purpose, rather than as an attitude toward a single technology.
• The supplied context does not report the study’s empirical results, so associations among perceived usefulness, acceptance constructs, and adoption intentions cannot be specified.

Clinical Implications

The article’s framing indicates that evaluation of generative AI–based DTx should account for the social and temporal circumstances that shape women’s access to care and judgments about technology. The supplied material does not provide empirical results or clinical recommendations, and it states that clinical evidence is required for DTx regardless of intended purpose.

Conclusion

The article positions women’s gendered healthcare circumstances as an important context for studying acceptance of generative AI–based DTx. The available source material describes the study rationale and method but does not provide results from which to draw conclusions about adoption intentions.

Related Resources & Content

1. DIGITAL HEALTH — The Impact of Perceived Features of AI Algorithmic Recommendations on the Adoption of Health Information: An Analysis Using PLS-SEM and fsQCA
2. Journal of Medical Internet Research (JMIR) — Relationship Between Generative AI Use and Life Satisfaction and the Mediating Role of AI Literacy Among Hong Kong Adults: Cross-Sectional Study
3. DIGITAL HEALTH — Psychiatrists’ experiences and opinions of generative AI: An exploratory online mixed methods survey in Germany
4. ASCO Publications — The use of generative AI tools by cancer patients and caregivers: A cross-sectional survey of awareness, attitudes, and experiences.
5. Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence-Enabled Device Software Functions | FDA
6. Large Language Model Chatbot Conversations vs Public Health Materials and Parental HPV Vaccination Intentions: A Randomized Clinical Trial | Public Health | JAMA Network Open | JAMA Network
7. Mapping the evidence supporting FDA-authorized digital therapeutics, before and after authorization | npj Digital Medicine